Moreover, the tumor volume in treated groups (including the PBMC group, anti-PD-1 Nb-Fc group, control Nb-Fc group, and mAb group) was much smaller compared with the untreated group (P<0.05). The gene discussed is PDCD1; the disease is neoplasm.